UMIN000051084
Exploration of Biomarkers for AFP-PIVKA-II Double-Negative Cases in Hepatocellular Carcinoma
Tottori University·University Hospital Medical Information NetworkEnrolling by invitation
Study focus
- Disease/Condition
- Hepatocellular carcinoma
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Tottori University
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Jan 17, 2023
- End date
- N/A
ICD-10 classifications
Malignant neoplasm: HepatoblastomaMalignant neoplasm: Liver cell carcinomaMalignant neoplasm: Other specified carcinomas of liverMalignant neoplasm: Liver, unspecifiedMalignant neoplasm: Hepatic flexure
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000051084
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000051084 through Pure Global AI's free database. This phase not specified trial is sponsored by Tottori University and is currently Enrolling by invitation. The study focuses on Hepatocellular carcinoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.